CLNN Clene Inc.
$3.57▼ -2.19%
ConsumerStaples
Other
After hours
$3.57▲ +0.00%
Sep 11, 7:30 PM ET
Volume 125.0K
Avg Volume (10D) 119.3K
Key Metrics & Fundamentals
Market Cap
$45.87M
P/E Ratio
–
Div Yield
–%
52W Range
3.48 - 13.50
% vs 50 MA
-27.82%
% vs 200 MA
-37.19%
RSI-14
29.5
MACD Histogram
-0.0300
Beta (1Y vs SPY)
1.93
Free Cash Flow
-$2.59M
Gross Rev
$90,000
Gross Profit
$54,000
EBITDA
-$4.91M
COGS
$36,000
Operating Exp
$5.22M
Operating Income
-$5.16M
EBIT
-$5.16M
Pretax Income
-$13.42M
Net Income
-$13.42M
EPS (Diluted)
-1.08
Price & Volume History
Loading chart…
Recent News

Clene to Present at Upcoming September Investor Conferences
GlobeNewswire · Sep 3, 2026 12:00 PM

Clene Eyes Q4 NDA for ALS Drug After FDA-Requested Biomarker Analyses
MarketBeat · Aug 19, 2026 10:03 PM

Presenting on Emerging Growth Conference 95 Day 1 on August 19; Register to live stream
GlobeNewswire · Aug 18, 2026 11:00 AM

Clene to Present at the Emerging Growth Conference
GlobeNewswire · Aug 17, 2026 12:30 PM

Clene Inc. (CLNN) Reports Q2 Loss, Beats Revenue Estimates
Zacks · Aug 14, 2026 1:20 PM

Clene Reports Second Quarter 2026 Financial Results and Recent Operating Highlights
GlobeNewswire · Aug 14, 2026 12:30 PM

Clene Targets Early Q4 NDA Filing for CNM-Au8 in ALS
MarketBeat · Aug 12, 2026 10:02 AM
Microbot Medical Inc. (MBOT) Reports Q2 Loss, Lags Revenue Estimates
Zacks · Aug 11, 2026 2:25 PM
Clene to Present at The Canaccord 46th Annual Growth Conference
GlobeNewswire · Jul 29, 2026 12:30 PM
Top Premarket Decliners
MT Newswires · Jun 22, 2026 11:32 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See CLNN's money flow as a full page
Social Sentiment
No Reddit posts found for CLNN.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.